telehealth glp-1 crackdown news today The FDA is cracking down on ‘misleading’ compounded GLP-1s from companies., Compounded weight loss drugs are not FDA-approved, which means the agency does not review their safety, Telehealth giant Hims & Hers

MTA members will continue to fight for affordable access to GLP-1 medications that have been life-changing for so many people. Beth Treffeisen is a general assignment reporter for Boston.com, focusing on local news, crime, and business in the New England region

O-GlcNAcylated c-Jun antagonizes ferroptosis via inhibiting GSH synthesis in liver cancer

Gray-market vials from overseas pharmacies

Heres what you should expect: Fasting blood sugar and HbA1c to spot undiagnosed diabetes or prediabetes

Santana added that he is happy the FDA advisory committee is meeting to discuss peptides

Small animal clinical pharmacology